Background Depression is a risk factor and complication of coronary artery disease (CAD) that is associated with poor ...

U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

Packaged food makers and fast-food restaurants may be forced to overhaul more of their products next year as newly approved, ...

A tiny supplement have been subbed as 'life-saving' by some people, but does Myrkl actually help prevent hangovers? I put it to the test.

Featuring three artists shaping the future of the industry: the country artist who bends genres; the singer-songwriter likely behind your favorite song; and the Puerto Rican rapper changing the game.

Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

This new pill contains the same active ingredient as injectable Wegovy and Ozempic, semaglutide. It is the first GLP-1 pill ...

The Wegovy pill's approval signifies a shift from injectable to oral dosage forms, driven by patient preference for ...

In the studies the company submitted to the FDA, people who took the daily Wegovy pill lost about the same amount of ...

On Monday evening, the Food and Drug Administration approved Novo Nordisk’s high-dose oral formulation of semaglutide for ...

LONDON, Dec 23 () - Novo Nordisk's newly approved weight-loss pill version of Wegovy will be a test case for the fast-growing ...

Losing weight hasn’t quite been the hardest part of modern obesity treatment. Keeping it off is. That’s exactly the problem ...